Good day, everyone, and welcome to Pfizer's Third-Quarter 2017 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chuck Triano, Senior Vice President of Investor Relations. Please …
Due to newly proposed rule changes by the U.S. Treasury Department targeting corporate tax inversion deals, Pfizer's board of directors voted on Tuesday to nix the $160 billion deal, which was the single largest merger agreement of …
The shares closed most recently at $24.49. This top pharmaceutical stock recently was added to the Merrill Lynch US 1 list. Pfizer Inc. (NYSE: PFE) has a very strong pipeline, and being the world’s largest drug manufacturer by sales value …
And according to sources close to the deal, first cited by the Financial Times on Sunday, Pfizer was finalizing an agreement that values Medivation at almost 30 percent premium to its current stock price of $67.16, its closing share …
Pfizer PFE is one of the largest pharmaceutical companies out there. With a market cap above $200 billion, many may think that the company doesn’t have much more room to grow its share price, but what’s not to love? The company has …
ICU Medical Inc : ICU Medical Inc to acquire the Hospira Infusion Systems business from Pfizer Inc for $1 billion in cash and stock . Deal for $1 billion . Pfizer will receive approximately $400 million in newly issued shares of ICU Medical …
This video takes a closer look at three top blue chip companies which may be in focus for investors this earnings season. After all, with recent risks to the market, investors have been focusing more on blue chips and large caps in general, …